Evidence map›Paper›PMID 38840611›Full record

ArticleSurgical neurology international2024

Intrasellar chordoma masquerading as a pituitary neuroendocrine tumor: Illustrative case.

Daisuke Sato, Hirotaka Hasegawa, Soichiro Kimura, Junichiro Sato, Yuki Shinya, Motoyuki Umekawa, Yoichi Yasunaga, Noriko Makita, Nobuhito Saito

Abstract readCase Reports
In one paragraph

Article in Surgical neurology international, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daisuke SatoDepartment of Neurosurgery, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Hirotaka HasegawaDepartment of Neurosurgery, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Soichiro KimuraDepartment of Endocrinology and Nephrology, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Junichiro SatoDepartment of Endocrinology and Nephrology, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Yuki ShinyaDepartment of Neurosurgery, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Motoyuki UmekawaDepartment of Neurosurgery, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Yoichi YasunagaDepartment of Pathology, Graduate School of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan.
Noriko MakitaDepartment of Endocrinology and Nephrology, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.
Nobuhito SaitoDepartment of Neurosurgery, University of Tokyo Hospital, Bunkyo-ku, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chordomas are rare, locally aggressive neoplasms recognized as derivatives of the notochord vestiges. These tumors typically involve the midline axial skeleton, and intracranial chordomas exhibit proclivity for the spheno-occipital region. However, purely intrasellar occurrences are extremely rare. We report a case of intrasellar chordoma, which masqueraded as a pituitary neuroendocrine tumor. Case Description: An 87-year-old female presented with an acutely altered mental state after a few-week course of headaches and decreased left vision. Adrenal insufficiency was evident, and magnetic resonance imaging revealed an intrasellar lesion with heterogeneous contrast enhancement and marked T2 hyperintensity. Central adrenal insufficiency due to an intrasellar lesion was suspected. Cortisol replacement was initiated, and transsphenoidal surgery was performed. Anterosuperior displacement of the normal pituitary gland and the absence of the bony dorsum sellae were notable during the procedure. Histological examination led to a diagnosis of conventional chordoma, and upfront adjuvant stereotactic radiosurgery was executed. She has been free from tumor progression for 12 months. Conclusion: This case and literature review suggested that the pathognomonic features of intrasellar chordoma were heterogeneous contrast enhancement, marked T2 hyperintensity, osteolytic destruction of the dorsum sellae, and anterosuperior displacement of the pituitary gland. Clinical outcomes seemed slightly worse than those of all skull base chordomas, which were the rationale for upfront radiosurgery in our case. Neurosurgeons should include intrasellar chordomas in the differential diagnosis of intrasellar lesions, carefully dissect them from the adjacent critical anatomical structures, and consider upfront radiosurgery to achieve optimal patient outcomes.

Indexed as

Endoscopic transnasal surgeryIntrasellar chordomaSellar tumorSkull base chordoma

Identifiers

PMID38840611
PMCPMC11152548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.